Insys Therapeutics, Inc. (NASDAQ:INSY) Posts Basic Consolidated EPS Of $0.8168

0

Insys Therapeutics, Inc. (NASDAQ:INSY)managed to report annual basic consolidated EPS of $0.8168, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $0.8168 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $0.0609.

EPS contribution from parent

Insys Therapeutics, Inc. (NASDAQ:INSY) received of $0.8168 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Insys Therapeutics, Inc. (NASDAQ:INSY) contributed EPS of $0.8168 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $0.8168.

What About Basic net EPS

The basic net EPS that Insys Therapeutics, Inc. (NASDAQ:INSY) reported for the year ended 2015-12-31 stood at $0.82. For the quarter ended 2015-12-31, the company posted basic net EPS of $0.82.

What About Consolidated Diluted EPS?

Insys Therapeutics, Inc. (NASDAQ:INSY)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $0.7724. For the quarter ended 2015-12-31 the metric was$0.7724.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $0.7724 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $0.7724.

Net diluted EPS

Net diluted EPS posted by Insys Therapeutics, Inc. (NASDAQ:INSY) for the year ended 2015-12-31 was $0.77. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $0.77.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Insys Therapeutics, Inc. (NASDAQ:INSY) said that it parent company boosted its diluted EPS by$0.7724 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $0.7724.

The company reported net basic EPS of $0.82 for the year ended 2015-12-31 and net basic EPS of $0.82 for the quarter ended 2015-12-31.

The number of Insys Therapeutics, Inc. (NASDAQ:INSY)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 71.593. That compares with 71.593 basic shares outstanding for the quarter ended 2015-12-31.

Insys Therapeutics, Inc. (NASDAQ:INSY) had 75.708 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 75.708.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 31 times, 1 visits today)